Scotiabank Charity Challenge

The Gastrointestinal Society is thrilled to announce that it will be participating in the 2017 Scotiabank Charity Challenge! The Vancouver races will be happening on June 25, 2017, and the GI Society needs YOUR help to raise funds and awareness for those living with gastrointestinal and liver conditions across Canada. Runners can participate in either [...]

By | April 13, 2017|Fundraiser, News|

The Importance of IBS Awareness Month

GASTROINTESTINAL SOCIETY SURVEY REVEALS MAJOR IMPACT OF IRRITABLE BOWEL SYNDROME (IBS) ON CANADIANS’ LIVES Gastrointestinal Society steps up to help patients this IBS Awareness Month Vancouver, BC – April 10, 2017 – To mark irritable bowel syndrome (IBS) Awareness Month this April, the Gastrointestinal Society has released the results of a recent survey of 2,961 [...]

By | April 10, 2017|News|

GI Society Joins Canadian Medical Cannabis Council

Gastrointestinal Society joins Canadian Medical Cannabis Council’s Patient Advisory Committee TORONTO (March 13, 2017) - Today, the Canadian Medical Cannabis Council (CMCC) announced that the Gastrointestinal (GI) Society has joined eight other leading patient groups from across Canada, as the newest member of the medical cannabis industry’s first Patient Advisory Committee (PAC). The Committee works [...]

By | March 13, 2017|News|

Is ‘Big Data’ a big deal for healthcare in Canada?

A survey to learn what people think about the use of large data sets for research purposes PURPOSE OF THIS STUDY: Big Data, in health care, is large and complex sets of data that have information routinely collected on patients’ health and their use of health care systems. The purpose of this study is to [...]

By | January 24, 2017|News|

Health Canada Approves Stelara®

HEALTH CANADA APPROVES STELARA® FOR THE TREATMENT OF ADULTS WITH MODERATELY TO SEVERELY ACTIVE CROHN’S DISEASE STELARA® offers a new approach to treating Crohn’s disease in Canada, which has one of the highest rates of this inflammatory bowel disease worldwide1 CNW – TORONTO, ON (December 14, 2016) — Janssen Inc. announced today that Health Canada [...]

By | December 16, 2016|News|

IBD Unmasked

Recognizing the heroic journey of people living with IBD We are proud to support the Canadian launch of IBD Unmasked, a first-of-its kind global awareness initiative developed though a unique collaboration between Takeda and the creative geniuses at Marvel Custom Solutions to support and empower the Inflammatory Bowel Disease (IBD) community. This unique initiative was [...]

By | December 7, 2016|News|

IBS Survey Results

IBS Survey Background The GI (Gastrointestinal) Society represents Canadians living with gastrointestinal diseases and disorders including those who have irritable bowel syndrome (IBS). We offer patient education on a wide array of GI conditions in text and video formats that covers the disease or disorder processes and provides descriptions of treatments available. The Society advocates [...]

By | December 6, 2016|News|

IBS Survey Follow-Up

In 2016, we created a survey for irritable bowel syndrome (IBS) patients, to help better understand how IBS affects people. Nearly 3,000 individuals responded, in both English and French. Click here to view the results of this survey. If you were one of the respondents, or if you didn't fill out the first survey but you [...]

By | November 30, 2016|News|

Takeda’s IBD Treatment ENTYVIO® (vedolizumab) Receives Prestigious Prix Galien Canada Innovative Product Award

OAKVILLE, ON - November 23, 2016 /CNW/ Takeda Canada is pleased to announce that ENTYVIO® (vedolizumab), a gut-selective biologic treatment to treat the two most common types of inflammatory bowel disease (IBD), has been named the 2016 winner of the prestigious Prix Galien Canada Innovative Product Award. The annual award, presented at a gala ceremony in [...]

By | November 29, 2016|News|
Load More Posts